Hello, this is Hall T. Martin with the Startup Funding Espresso -- your daily shot of startup funding and investing.

In pitching investors, there are many ways to blow the pitch.

Here’s a list of common mistakes startups make:

Losing your temper and letting emotions get the better of you.

Investors want level-headed people they can work with.

Building the company only for the exit.  

There must be a “why” behind the business.

Inability to present the idea or business in a smooth way.

Lack of clarity in the pitch will translate into a lack of clarity regarding the business plan.

Not answering the investors’ questions, such as failing to give revenue numbers.

Lack of direct answers frustrates the investors and leads many to believe the answer is not attractive.

Not knowing your industry or market.

It’s best to demonstrate knowledge of the market with some key numbers.

Not knowing your team well.

It’s best to have some history with the team members and demonstrate how you work well together. 


Thank you for joining us for the Startup Funding Espresso where we help startups and investors connect for funding.

Let’s go startup something today.
___________________________________

For more episodes from Investor Connect, please visit the site at: http://investorconnect.org 

Check out our other podcasts here: https://investorconnect.org/ 
For Investors check out: https://tencapital.group/investor-landing/ 
For Startups check out: https://tencapital.group/company-landing/ 
For eGuides check out: https://tencapital.group/education/ 
For upcoming Events, check out https://tencapital.group/events/ 

For Feedback please contact info@tencapital.group  

Music courtesy of Bensound

This is Investor Perspectives. I’m the host of Investor Connect, Hall T Martin, where we connect startups and investors for funding.

In our new Investor Perspectives series entitled “How to Solve the Biotech/Life Sciences Problem”, you’ll hear about participation in the Biotech/Life Sciences segment and what investors look for.

As the COVID pandemic passes, we emerge into a new world. The biotech space is now undergoing tremendous change as we shift back to a normal way of life. The process for designing and approving vaccines demonstrated a new protocol. Biotech now moves into a new era. We have investors and startup founders describe the changes coming up.

Our guests are:

Yaniv Sneor, Co-founder, Mid Atlantic Bio Angels 01:18
Carter Williams, CEO and Managing Partner, iSelect Fund 08:50
Maximilian Bade, Founding Partner, Nucleus Capital 15:31
Ron Paliwoda, President, Paliwoda Group 20:15
Orrin Ailloni-Charas, Managing Partner, Global Health Impact Fund 26:00
Eyal Lifschitz, Co-Founder and Managing Partner, Peregrine Ventures 30:05
Mark Groper, Chief Executive Officer, Orion Biotechnology 37:20

We hope you enjoy the show.

For more episodes from Investor Connect, please visit the site at: http://investorconnect.org     

Check out our other podcasts here: https://investorconnect.org/ 
For Investors check out: https://tencapital.group/investor-landing/ 
For Startups check out: https://tencapital.group/company-landing/  
For eGuides check out: https://tencapital.group/education/ 
For upcoming Events, check out https://tencapital.group/events/

For Feedback please contact info@tencapital.group  

Music courtesy of Bensound